Current status of bariatric surgery in the treatment of type 2 diabetes

Obesity Reviews

Volumn 5, Issue 1, 2004, Pages 69-78

  Pinkney, J ^a,b   Kerrigan, D ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Bariatric surgery; Diabetes; Obesity

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

BARIATRIC SURGERY; BODY MASS; COMORBIDITY; DIABETIC DIET; FOLLOW UP; GASTRIC BANDING; GASTROPLASTY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN SENSITIVITY; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT SELECTION; REVIEW; STOMACH BYPASS; SURGICAL TECHNIQUE; WEIGHT REDUCTION;

BILIOPANCREATIC DIVERSION; BODY MASS INDEX; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; GASTRIC BYPASS; GASTROPLASTY; HUMANS; OBESITY; PATIENT SELECTION; WEIGHT LOSS;

EID: 0842269195     PISSN: 14677881     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2004.00119.x     Document Type: Review

References (69)

1. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481-486.
2. Chan JM, Stampfer MJ, Rimm EB, Willett WC, Colditz GA. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17: 961-969.
3. Mason EE, Renquist K, Jiang D. Predictors of two obesity complications; diabetes and hypertension. Obes Surg 1992; 2: 231-237.
4. Kral JG. Morbidity of severe obesity. Surg Clin North Am 2001; 81: 1039-1061.
5. Sjostrom CD, Lissner L, Wedel H, Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study. Obesity Res 1999; 7: 477-485.
6. Pories WJ, Swanson M, MacDonald KG, Long SD, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, Dohm L. Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg 1995; 222: 339-352.
7. Pories WJ, MacDonald KG, Morgan EJ, Sinha MK, Dohm GL, Swanson MS, Barakat HA, Khazanie PG, Leggett-Frazier N, Long SD. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 1992; 55: 582S-585S.
8. Cowan CGM, Buffington CK. Significant changes inignifi blood pressure, glucose and lipids with gastric bypass surgery. World J Surg 1998; 22: 987-992.
9. Gleysteen JG, Barboriak JJ, Sasse EA. Sustained coronary risk factor reduction after gastric bypass for morbid obesity. Am J Clin Nutr 1990; 51: 774-778.
10. Wittgrove AC, Clark W, Schubert KR. Laparoscopic gastric bypass, Roux-en-Y: technique and results in 75 patients with 3-30 months follow-up. Obes Surg 1996; 6: 500-504.
11. Sjöström CD, Peltonen M, Wedel H, Sjöström L. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000; 36: 20-25.
12. Long SD, O'Brien K, MacDonald KG, Leggett-Frazier N, Swanson MS, Pories WJ, Caro JF. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. Diabetes Care 2003; 17: 372-375.
13. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-93. Diabetes Care 1998; 21: 1138-1145.
14. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. Br Med J 2001; 322: 1389-1393.
15. Cho E, Manson JE, Stampfer MJ, Solomon CG, Colditz GA, Speizer FE, Willett WC, Hu FB. A prospective study of obesity and risk of coronary heart disease among diabetic women. Diabetes Care 2002; 25: 1142-1148.
16. Daousi C, Pinkney JH. The impact of obesity on the prevalence of cardiovascular disease and diabetic complications in a hospital diabetic population. Diabet Med 2003; 20: 102 [Abstract].
17. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso. M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1390-1392.
18. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
19. LeRoith D. β-cell dysfunction and insulin resistance in type 2 diabetes. Role of metabolic and genetic abnormalities. Am J Med 2002; 113: 3S-11S.
20. UK Prospective Diabetes Study. V. Characteristics of newly presenting type 2 diabetic patients: estimated insulin sensitivity and islet β-cell function. Multi-centre study. Diabet Med 1988; 5: 444-448.
21. Singh BM, Jackson DM, Wills R, Davies J, Wise PH. Delayed diagnosis of non-insulin dependent diabetes. Br Med J 1992; 304: 1154-1155.
22. Porte D, Kahn SE. Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes 2001; 50: S160-S163.
23. Henry RR, Wallace P, Olefsky JM. Effects of weight loss on mechanisms of hyperglycaemia in obese non-insulin-dependent diabetes mellitus. Diabetes 1986; 35: 990-998.
24. Hanefeld M, Weck M. Very low calorie diet therapy in obese non-insulin dependent diabetes patients. Int J Obes 1989; 13: 33-37.
25. Fukuda M, Tahara Y, Yamamoto Y, Onishi T, Kumahara Y, Tanaka A, Shima K. Effects of very low calorie diet weight reduction on glucose tolerance, insulin secretin, and insulin resistance in obese non-insulin dependent diabetics. Diabetes Res Clin Pract 1989; 7: 61-69.
26. Di Biase G, Mattioli PL, Contaldo F, Mancini M. A very low calorie formula diet (Cambridge Diet) for the treatment of diabetic-obese patients. Int J Obes 1981; 5: 319-324.
27. Wing RR, Marcus RD, Salata R, Epstein LH, Miaskiewicz S, Blair E. Effects of a very low calorie diet on long term glycaemic control in obese type 2 diabetic subjects. Arch Intern Med 1991; 151: 1334-1340.
28. Rotella CM, Cresci B, Mannucci E, Rizzello SM, Colzi G, Galli G, Giannini S, Messeri G, Piani F, Vannini R, Bucalossi A, Conti A, Serio M. Short cycles of very low calorie diet in the therapy of obese type 2 diabetes mellitus. J Endocrinol Invest 1994; 17: 171-179.
29. Wing RR, Blair E, Marcus M, Epstein LH, Harvey J. Year-long weight loss treatment for obese patients with type II diabetes: does including an intermittent very low calorie diet improve outcomes? Am J Med 1994; 97: 354-362.
30. Capstick F, Brokks BA, Burns CM, Zilkens RR, Steinbeck KS, Yue DK. Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient. Diabetes Res Clin Pract 1997; 36: 105-111.
31. Williams KV, Mullen ML, Kelley DE, Wing RR. The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care 1998; 21: 2-8.
32. Wing RR, Epstein LH, Paternostro-Bayles M, Kriska A, Nowalk MP, Gooding W. Exercise in a behavioral weight control programme for obese patients with type-2 (non-insulin dependent diabetes). Diabetologia 1988; 31: 902-909.
33. Wing RR. Behavioral treatment of obesity. Its application to type-II diabetes. Diabetes Care 1993; 16: 193-199.
34. Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000; 23: 1451-1452.
35. Zilli FCM, Croci M, Tufano A, Caviezel F. The compliance of hypocaloric diet in type 2 diabetic obese patients: a brief term study. Eat Weight Disord 2000; 5: 217-222.
36. Watts NB, Spanheimer RG, DiGirolamo M, Gebhart SS, Musey VC, Siddiq YK, Phillips LS. Prediction of glucose response to weight loss in patients with non-insulin dependent diabetes mellitus. Arch Intern Med 1990; 151: 198-201.
37. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. Diet, lifestyle, and risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345: 790-797.
38. Pinkney JH, Sjostrom CD, Gale EAM. Should surgeons treat diabetes in very obese people? Lancet 2001; 357: 1357-1359.
39. Herbst CA, Hughes TA, Gwynne JT, Buckwalter JA. Gastric bariatric operation in insulin-treated adults. Surgery 1984; 95: 209-214.
40. Brolin RE. Results of obesity surgery. Gastroenterol Clin North Am 1987; 16: 317-338.
41. Reinhold RB. Late results of gastric bypass surgery for morbid obesity. J Am Coll Nutr 1994; 13: 326-331.
42. MacGregor AMC, Rand CSW. Gastric surgery in morbid obesity. Arch Surg 1993; 128: 1153-1157.
43. Scheen AJ. Aggressive weight reduction treatment in the management of type-2 diabetes. Diabet Metabolism 1998; 24: 116-123.
44. Stieger R, Thurnheer M, Lange J. Morbide Obesitas: Ergebnisse des laparoscopic gastric banding bei 130 konsekutiven patienten. Schweiz Med Wochenschr 1998; 128: 1239-1246.
45. Dixon JB, O'Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002; 25: 358-363.
46. MacDonald KG, Long S, Swanson M, Brown BM, Morris P, Dohm GL, Pories WJ. The gastric bypass operation reduces the progression and mortality of non-insulin dependent diabetes mellitus. J Gastrointest Surg 1997; 1: 213-220.
47. Sjöström L. Surgical intervention as a strategy for the treatment of obesity. Endocrine 2000; 13: 213-230.
48. Letiexhe MR, Scheen AJ, Gerard PL, Desaive C, Lefebvre PJ. Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism. J Clin Endocrinol Metab 1995; 80: 364-369.
49. Greenway SE, Greenway FL, Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg 2002; 137: 1109-1117.
50. Mason EE. Vertical band gastroplasty for obesity. Arch Surg 1982; 117: 701-706.
51. Weiner R, Wagner D, Bockhorn H. Laparoscopic gastric banding for morbid obesity. J Laparoendosc Adv Surg Tech A 1999; 9: 23-30.
52. Miller K, Hell E. Laparoscopic adjustable gastric banding. Obesity Surg 1999; 9: 183-187.
53. Nehoda H, Weiss H, Labeck B, Hourmont K, Lanthaler M, Oberwalder M, Aigner F. Results and complications after adjustable gastric banding in a series of 250 patients. Am J Surg 2001; 181: 12-15.
54. Pier A, Abtahi G, Lippert H. Chirurgische therapie der pathologischen adipositas durch laparoskopisches 'gastric banding' teknik und ergebnisse in 370 fallen. Chirurg 1999; 70: 196-205.
55. Fielding GA, Rhodes M, Nathanson LK. Laparoscopic gastric banding for morbid obesity. Surg Endoscopy 1999; 13: 550-554.
56. Zinzindohoue F, Chevallier JM, Douard R, Elian N, Ferraz JM, Blanche JP, Berta JL, Altman JJ, Safran D, Cugnene PH. Laparoscopic gastric banding: a minimally invasive surgical treatment for morbid obesity, prospective study of 500 consecutive patients. Ann Surg 2003; 237: 1-9.
57. Halverson JD, Scheff RJ, Gentry K, Alpers DH. Jejunoileal bypass. Late metabolic sequelae and weight gain. Am J Surg 1980; 140: 347-350.
58. Mason EE, Ito C. Gastric bypass. Ann Surg 1969; 170: 329-339.
59. Scopinaro N, Gianetta E, Adami GF, Scopinaro N, Gianetta E, Adami GF, Friedman D, Traverso E, Marinari GM, Cuneo S, Vitale B, Ballari F, Colombini M, Baschieri G, Bachi V. Biliopancreatic diversion for obesity at 18 years. Surgery 1996; 119: 261-268.
60. Flickinger EG, Pories WJ, Meelheim HD, Sinar DR, Blose IL, Thomas FT. The Greenville Gastric Bypass. Ann Surg 1984; 199: 555-562.
61. National Institutes of Health Consensus Development conference. Am J Clin Nutr 1992; 55: 487S-619S.
62. Stunkard AJ, Stinnett JL, Smoller JW. Psychological and social aspects of the surgical treatment of obesity. Am J Psychiatry 1986; 143: 417-429.
63. Livingston EH, Huerta S, Arthur D, Lee S, De Shields S, Heber D. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg 2003; 236: 576-582.
64. Sugarman HJ, Sugarman EL, DeMaria EJ, Kellum JM, Kennedy C, Mowery Y, Wolfe LG. Bariatric surgery for severely obese adolescents. J Gastrointest Surg 2003; 7: 102-108.
65. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988; 37: 667-687.
66. Singh BM, Jackson DM, Wills R, Davies J, Wise PH. Delayed diagnosis in non-insulin dependent diabetes mellitus. Br Med J 1992; 304: 1154-1115.
67. Wang J, Obici S, Morgan K, Barzilai N, Feng Z, Rossetti L. Overfeeding rapidly induces leptin and insulin resistance. Diabetes 2001; 50: 2786-2791.
68. Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J. Role of orlistat in the treatment of obese patients with type-2 diabetes. Diabetes Care 1998; 21: 1288-1294.
69. Kelley DE, Bray GA, Pi-Sunyer FX, Klein S, Hill J, Miles J, Hollander PA. Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes. Diabetes Care 2002; 25: 1033-1041.